EMG
IMMU

Ellington Management Group’s Immunomedics Inc IMMU Stock Holding History

Ellington Management Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-26,800
Closed -$567K – 834
2019
Q4 		$567K Buy
+26,800
New +$473K 0.12% 144
2019
Q2 		– Sell
-81,900
Closed -$1.57M – 863
2019
Q1 		$1.57M Buy
+81,900
New +$1.32M 0.29% 89
2013
Q3 		– Sell
-86,000
Closed -$468K – 1040
2013
Q2 		$468K Buy
+86,000
New +$282K 0.09% 339

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellington Management Group's IMMU Position: Q1 2020 in Review

Ellington Management Group sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 26,800 shares — an estimated $567K sold.

Ellington Management Group first reported a position in IMMU in Q2 2013 and held it in 3 quarters. The position peaked at $1.57M in Q1 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Ellington Management Group reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 26,800 Immunomedics Inc shares in Q1 2020, an estimated $567K.
  • Ellington Management Group first reported a position in Immunomedics Inc in Q2 2013 and held it in 3 quarters.
  • Ellington Management Group's Immunomedics Inc position peaked at $1.57M in Q1 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.